In contrast, in CCA, increased expression of OX40 on PBMC-derived Th and CD8+ T cell was rather correlated to improved recurrence-free survival, hinting to a potential anti-tumour effect (128). The gene discussed is CD8A; the disease is cholangiocarcinoma.